EUVIMEDEUVIMED entdecken
Crossref

Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway

Shangwei Xu iD, Chunji Chen, Hongwei Liu, Shuai Jiang, Zheng Li, Yun Wu

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.70007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Shangwei Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Proto-Oncogene Proteins c-akt, Lung Neoplasms, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: This study was supported by Huadong Hospital Affiliated to Fudan University, Wu Jieping Medical Foundation and National Nature Cultivation Youth Project..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is characterized by high aggressiveness and lethality, processing in‐depth molecular mechanism investigation is particularly necessary. In our study, we found that osteoglycin (OGN) deficiency is strongly associated with a poor prognosis in lung adenocarcinoma (LUAD). OGN overexpression could inhibit the proliferation, migration, and invasion of LUAD cells. Through transcriptome sequencing analysis and experimental validation, we revealed that such OGN ‐mediated tumor suppression effect was related to cell adhesion function induced by ICAM1 downregulation, along with regulation by the PI3K/AKT signaling pathway. The present study demonstrated the specific mechanism of OGN involvement in LUAD progression, providing new evidence and potential targets for research on cancer suppression in LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungProto-Oncogene Proteins c-aktLung NeoplasmsPhosphatidylinositol 3-KinasesIntercellular Adhesion Molecule-1HumansCell AdhesionSignal TransductionCell ProliferationGene Expression Regulation, NeoplasticCell MovementDisease ProgressionPrognosisCell Line, TumorAnimalsMiceMaleFemale

Stichwörter der Autor:innen

cell adhesionlung adenocarcinomametastasisosteoglycin (OGN)

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesIntercellular Adhesion Molecule-1ICAM1 protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
  • Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Respiratory Medicine, Shanghai Fengxian District Central Hospital, Shanghai, China.

ORCID-Profile: Shangwei Xu

Förderung

  • This study was supported by Huadong Hospital Affiliated to Fudan University, Wu Jieping Medical Foundation and National Nature Cultivation Youth Project.

Zitieren

APA

Xu, S., Chen, C., Liu, H., Jiang, S., Li, Z., & Wu, Y. (2025). Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70007

Vancouver

Xu S, Chen C, Liu H, Jiang S, Li Z, Wu Y. Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70007

BibTeX
@article{Xu2025,
  author = {Xu, Shangwei and Chen, Chunji and Liu, Hongwei and Jiang, Shuai and Li, Zheng and Wu, Yun},
  title = {Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.70007}
}
Kostenlos starten →